---
layout: minimal-medicine
title: Dolutegravir + Emtricitabine + Tenofovir Alafenamide
---

# Dolutegravir + Emtricitabine + Tenofovir Alafenamide
### Generic Name
Dolutegravir + Emtricitabine + Tenofovir Alafenamide (DTA)

### Usage
Dolutegravir + Emtricitabine + Tenofovir Alafenamide (often referred to as DTA) is a fixed-dose combination of three antiretroviral medications used to treat Human Immunodeficiency Virus type 1 (HIV-1) infection.  It's a complete regimen for most adults and children (weighing at least 25 kg) newly diagnosed with HIV-1. This means it provides all the necessary medications in a single pill, simplifying adherence.  While primarily used as a first-line treatment for HIV, it might also be used in certain situations as part of a second-line regimen if other drugs have failed or caused intolerance. DTA's efficacy lies in its ability to suppress viral load and improve CD4+ T-cell counts, thereby slowing the progression of HIV infection and improving the patient’s overall health.


### Dosage

**Adults and Adolescents (≥12 years, ≥25 kg):** The usual dose is one tablet taken orally once daily with or without food.  There's no dosage adjustment needed based on weight in this age group.

**Children (under 12 years and/or weighing <25kg):**  DTA is not approved for use in children under the age of 12 or weighing less than 25kg.  Alternative formulations or combinations of antiretroviral drugs may be necessary for this age group and weight range.  A healthcare provider must make this determination based on the individual child's needs.  


**IV Administration:** Dolutegravir, emtricitabine, and tenofovir alafenamide are not available in intravenous (IV) formulations. They are administered orally only.

**Dosage Adjustments:** Dosage adjustments might be necessary in cases of renal impairment (kidney problems).  A doctor will assess kidney function and adjust the dose or medication accordingly.


### Side Effects

* **Common side effects:**  Headache, nausea, diarrhea, fatigue, dizziness, rash, and abnormal dreams. These are typically mild and usually resolve with continued treatment.
* **Less common but serious side effects:**  Severe allergic reactions (anaphylaxis), liver problems (hepatitis), pancreatitis, kidney problems (renal failure), increased risk of fractures (bone-related side effects), and changes in body fat distribution (lipodystrophy).  
* **Important Note:**  If any concerning side effects develop, it's crucial to contact a healthcare provider immediately.

### How it Works

DTA works by targeting different stages of the HIV life cycle:

* **Dolutegravir:**  This is an integrase strand transfer inhibitor (INSTI). It prevents the HIV virus from integrating its genetic material into the DNA of human cells, blocking viral replication.
* **Emtricitabine:** A nucleoside reverse transcriptase inhibitor (NRTI). It inhibits reverse transcriptase, an enzyme necessary for HIV to replicate its genetic material.
* **Tenofovir Alafenamide:**  Another NRTI. Like emtricitabine, it inhibits reverse transcriptase, but it's a newer, improved version of tenofovir disoproxil fumarate (TDF), with better tolerability and less impact on kidney function.


By combining these three drugs, DTA effectively suppresses HIV replication at multiple points in its life cycle, leading to a significant reduction in viral load and improved immune function.

### Precautions

* **Allergic Reactions:** Individuals with a known hypersensitivity to any of the components should avoid DTA.
* **Drug Interactions:** DTA can interact with other medications. Always inform your doctor about all medications (prescription, over-the-counter, and herbal supplements) you are taking.  Some interactions can significantly affect the efficacy or increase the risk of side effects.
* **Renal Impairment:**  Patients with impaired kidney function need careful monitoring and potential dose adjustments.
* **Pregnancy and Breastfeeding:**  While generally considered safe for pregnant and breastfeeding women, the potential risks and benefits should be discussed with a healthcare provider.  
* **Hepatic Impairment:** People with liver problems should be closely monitored during treatment.
* **Bone health:**  Long-term use may have a subtle negative effect on bone mineral density. This risk is usually minor and manageable with good nutrition and lifestyle choices but may need additional monitoring for some patients.

### FAQs

* **Q: Can I drink alcohol while taking DTA?** A:  Moderation is advised. Excessive alcohol consumption can negatively impact liver health, which is important when taking DTA. Discuss this with your doctor.

* **Q: How should I store DTA?** A: Store DTA at room temperature, away from moisture and direct sunlight.

* **Q: What should I do if I miss a dose?** A: Take it as soon as you remember, unless it's almost time for your next dose. Never double the dose to make up for a missed one.

* **Q:  Can I stop taking DTA when my viral load is undetectable?** A: No, you should continue taking DTA as prescribed by your doctor, even if your viral load is undetectable. This is crucial to maintain viral suppression and prevent drug resistance.

* **Q:  What are the long-term effects of DTA?** A: While long-term use is generally safe and effective, ongoing monitoring for potential side effects, especially renal and bone health, is recommended by healthcare providers.  Always maintain open communication about your health with your doctor.


**Disclaimer:** This information is for educational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting or stopping any medication, especially if you have pre-existing health conditions or are taking other medications.  They can assess your individual needs and provide personalized guidance.
